Age-related macular degeneration (AMD) is mainly characterized by the progressive accumulation of drusen deposits and loss of photoreceptors and retinal pigment epithelial (RPE) cells. Because amyloid β (Aβ) is the main component of drusen, Aβ-induced activated microglia most likely lead to neuroinflammation and play a critical role in the pathogenesis of AMD. However, the relationship between activated microglia–mediated neuroinflammatory cytokines and photoreceptor death has not been clarified. By subretinal injection of Aβ42 in mice, we mimicked an inflammatory milieu of AMD to better understand how activated microglia–induced neuroinflammatory cytokines lead to photoreceptor apoptosis in the AMD progression. We demonstrated that subretinal injection of Aβ42 induces microglial activation and increases inflammatory cytokine release, which gives rise to photoreceptor apoptosis in mice. Our results were verified in vitro by co-culture of Aβ42 activated primary microglia and the photoreceptor cell line 661W. We also demonstrated that the p38 mitogen-activated protein kinase (MAPK) signaling pathway was involved in Aβ42-induced microglial activation and inflammatory cytokine release. Overall, our findings indicate that activated microglia–derived neuroinflammatory cytokines could contribute to photoreceptor apoptosis under the stimulation of Aβ42. Moreover, this study may provide a potential therapeutic approach for AMD.
Further explore the association between activated microglia–derived neuroinflammatory cytokine secretion and photoreceptor apoptosis under the stimulation of Aβ42.
Subretinal injection of Aβ42 induces the activation of microglia and increases proinflammatory cytokines IL-1β and COX-2 expression in the retina, which could give rise to the deterioration of visual function and aggravate photoreceptor apoptosis in mice.
Primary microglial are activated and the levels of proinflammatory cytokines are increased by Aβ42 stimulation, which could increase the apoptosis of photoreceptor cell line 661W in vitro.
The p38 MAPK signaling pathway is involved in microglial activation and photoreceptor apoptosis under Aβ42 treatment.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Jingfa Zhang and Fang Liu are guarantors of this work, who have full access to all the data in this study and take responsibility for the integrity and accuracy of the data. Data are available from the corresponding authors on reasonable request.
Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health 2:e106–e116
Sivak JM (2013) The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease. Invest Ophthalmol Vis Sci 54:871–880
Wu J, Zhang X, Azhati G, Li T, Xu G, Liu F (2020) Retinal microvascular attenuation in mental cognitive impairment and Alzheimerʼs disease by optical coherence tomography angiography. Acta ophthalmologica. 98. https://doi.org/10.1111/aos.14381
Qu SC, Xu D, Li TT, Zhang JF, Liu F (2019) iTRAQ-based proteomics analysis of aqueous humor in patients with dry age-related macular degeneration. Int J Ophthalmol 12:1758–1766
Ohno-Matsui K (2011) Parallel findings in age-related macular degeneration and Alzheimer’s disease. Progress in Retinal and Eye Research 30:217–238
Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S, Houssier M, Jonet L, Picard E, Debré P, Sirinyan M, Deterre P, Ferroukhi T, Cohen SY, Chauvaud D, Jeanny JC, Chemtob S, Behar-Cohen F, Sennlaub F (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. Journal of Clinical Investigation 117:2920–2928
Zhu M, Wang X, Schultzberg M, Hjorth E (2014) Differential regulation of resolution in inflammation induced by amyloid-β42 and lipopolysaccharides in human microglia. Journal of Alzheimerʼs Disease 43:1237–1250
Cai Z, Hussain MD, Yan LJ (2014) Microglia, neuroinflammation, and beta-amyloid protein in Alzheimerʼs disease. The International journal of neuroscience 124:307–321
Felsky D, Roostaei T, Nho K, Risacher SL, Bradshaw EM, Petyuk V, Schneider JA, Saykin A, Bennett DA, De Jager PL (2019) Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nature Communications 10:409
Lu Y, Guo Z, Zhang Y, Li C, Zhang Y, Guo Q, Chen Q, Chen X, He X, Liu L et al (2019) Microenvironment remodeling micelles for Alzheimerʼs disease therapy by early modulation of activated microglia. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 6:1801586
Braun DJ, Dimayuga E, Morganti JM, Van Eldik LJ (2020) Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimerʼs disease. J Neuroinflammation 17:274
Dong ZZ, Li J, Gan YF, Sun XR, Leng YX, Ge J (2018) Amyloid beta deposition related retinal pigment epithelium cell impairment and subretinal microglia activation in aged APPswePS1 transgenic mice. Int J Ophthalmol 11:747–755
Puertas-Neyra K, Usategui-Martin R, Coco RM, Fernandez-Bueno I (2020) Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases. Neural regeneration research 15:1631–1638
Gasparini SJ, Llonch S, Borsch O, Ader M (2019) Transplantation of photoreceptors into the degenerative retina: current state and future perspectives. Prog Retin Eye Res 69:1–37
Nebel C, Aslanidis A, Rashid K, Langmann T (2017) Activated microglia trigger inflammasome activation and lysosomal destabilization in human RPE cells. Biochemical and Biophysical Research Communications 484:681–686
Grimaldi A, Pediconi N, Oieni F, Pizzarelli R, Rosito M, Giubettini M, Santini T, Limatola C, Ruocco G, Ragozzino D, di Angelantonio S (2019) Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimerʼs disease patients, possible biomarkers for early diagnosis. Front Neurosci 13:925
Perry VH, Nicoll JAR, Holmes C (2010) Microglia in neurodegenerative disease. Nature Reviews Neurology 6:193–201
Cheng YW, Chang CC, Chang TS, Li HH, Hung HC, Liu GY, Lin CL (2018) Aβ stimulates microglial activation through antizyme-dependent downregulation of ornithine decarboxylase. Journal of Cellular Physiology 234:9733–9745
Do KV, Kautzmann MI, Jun B, Gordon WC, Nshimiyimana R, Yang R, Petasis NA, Bazan NG (2019) Elovanoids counteract oligomeric beta-amyloid-induced gene expression and protect photoreceptors. Proc Natl Acad Sci U S A 116:24317–24325
Fu Y, Hou B, Weng C, Liu W, Dai J, Zhao C, Yin ZQ (2017) Functional ectopic neuritogenesis by retinal rod bipolar cells is regulated by miR-125b-5p during retinal remodeling in RCS rats. Scientific Reports 7. https://doi.org/10.1038/s41598-017-01261-x
Gao G, Zhao S, Xia X, Li C, Li C, Ji C, Sheng S, Tang Y, Zhu J, Wang Y, Huang Y, Zheng JC (2019) Glutaminase C regulates microglial activation and pro-inflammatory exosome release: relevance to the pathogenesis of Alzheimer’s disease. Frontiers in Cellular Neuroscience 13. https://doi.org/10.3389/fncel.2019.00264
Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss N, Pav S, Regan J (2002) Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature structural biology 9:268–272
Zhou T, Huang Z, Sun X, Zhu X, Zhou L, Li M, Cheng B, Liu X, He C (2017) Microglia polarization with M1/M2 phenotype changes in rd1 mouse model of retinal degeneration. Front Neuroanat 11:77
Wolf SA, Boddeke HW, Kettenmann H (2017) Microglia in physiology and disease. Annu Rev Physiol 79:619–643
Yeung YT, Aziz F, Guerrero-Castilla A, Arguelles S (2018) Signaling pathways in inflammation and anti-inflammatory therapies. Current pharmaceutical design 24:1449–1484
Schultz N, Byman E, Wennström M (2020) Levels of retinal amyloid-β correlate with levels of retinal IAPP and hippocampal amyloid-β in neuropathologically evaluated individuals. J Alzheimers Dis 73:1201–1209
Qiu T, Liu Q, Chen YX, Zhao YF, Li YM (2015) Abeta42 and Abeta40: similarities and differences. J Pept Sci 21:522–529
Muraleva NA, Kozhevnikova OS, Fursova AZ, Kolosova NG (2019) Suppression of AMD-like pathology by mitochondria-targeted antioxidant SkQ1 is associated with a decrease in the accumulation of amyloid β and in mTOR activity. Antioxidants (Basel, Switzerland) 8. https://doi.org/10.3390/antiox8060177
Parsons CG, Ruitenberg M, Freitag CE, Sroka-Saidi K, Russ H, Rammes G (2015) MRZ-99030 - a novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimerʼs disease, glaucoma and age-related macular degeneration (AMD). Neuropharmacology 92:158–169
Aslanidis A, Karlstetter M, Scholz R, Fauser S, Neumann H, Fried C, Pietsch M, Langmann T (2015) Activated microglia/macrophage whey acidic protein (AMWAP) inhibits NFkappaB signaling and induces a neuroprotective phenotype in microglia. J Neuroinflammation 12:77
Ma W, Silverman SM, Zhao L, Villasmil R, Campos MM, Amaral J, Wong WT (2019) Absence of TGFβ signaling in retinal microglia induces retinal degeneration and exacerbates choroidal neovascularization. eLife 8. https://doi.org/10.7554/eLife.42049
Grimaldi A, Brighi C, Peruzzi G, Ragozzino D, Bonanni V, Limatola C, Ruocco G, Di Angelantonio S (2018) Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model. Cell Death & Disease 9:685
Haenseler W, Rajendran L (2019) Concise review: modeling neurodegenerative diseases with human pluripotent stem cell-derived microglia. Stem Cells 37:724–730
He J, Zhao C, Dai J, Weng CH, Bian BSJ, Gong Y, Ge L, Fang Y, Liu H, Xu H, Yin ZQ (2019) Microglia mediate synaptic material clearance at the early stage of rats with retinitis pigmentosa. Front Immunol 10:912
Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30–57
Kaur D, Sharma V, Deshmukh R (2019) Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease. Inflammopharmacology 27:663–677
Pennesi ME, Neuringer M, Courtney RJ (2012) Animal models of age related macular degeneration. Molecular aspects of medicine 33:487–509
Cai X, McGinnis JF (2016) Nanoceria: a potential therapeutic for dry AMD. Advances in experimental medicine and biology 854:111–118
Weng NP, Pawelec G (2019) Research on immunity and ageing comes of age. Immunity & ageing : I & A 16:8
Arroba AI, Campos-Caro A, Aguilar-Diosdado M, Valverde ÁM (2018) IGF-1, Inflammation and retinal degeneration: a close network. Front Aging Neurosci 10:203
Kim SY (2015) Retinal phagocytes in age-related macular degeneration. Macrophage (Houst) 2. https://doi.org/10.14800/macrophage.698
Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jamison JA, Kelly U, Harrabi O, Bollini SS, Dilley J, Kobayashi D, Kuang B, Li W, Pons J, Lin JC, Rickman CB (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A 108:E279–E287
Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN (2016) Eliminating microglia in Alzheimerʼs mice prevents neuronal loss without modulating amyloid-β pathology. Brain 139:1265–1281
Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W, Lin J, Phan NY, Habets G, Rymar A, Tsang G, Walters J, Nespi M, Singh P, Broome S, Ibrahim P, Zhang C, Bollag G, West BL, Green KN (2019) Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimerʼs disease model. Nat Commun 10:3758
Sosna J, Philipp S, Albay R 3rd, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, Glabe CG (2018) Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease. Mol Neurodegener 13:11
Rathnasamy G, Foulds WS, Ling EA, Kaur C (2019) Retinal microglia - a key player in healthy and diseased retina. Prog Neurobiol 173:18–40
Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10–20
Joly S, Francke M, Ulbricht E, Beck S, Seeliger M, Hirrlinger P, Hirrlinger J, Lang KS, Zinkernagel M, Odermatt B, Samardzija M, Reichenbach A, Grimm C, Remé CE (2009) Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. The American journal of pathology 174:2310–2323
Freund A, Patil CK, Campisi J (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. The EMBO journal 30:1536–1548
Davis T, Brook A, Rokicki M, Bagley M, Kipling D (2016) Evaluating the role of p38 MAPK in the accelerated cell senescence of Werner syndrome fibroblasts. Pharmaceuticals 9. https://doi.org/10.3390/ph9020023
Chen X, Chen X, Zhang X, Wang L, Cao P, Rajamanickam V, Wu C, Zhou H, Cai Y, Liang G et al (2019) Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Redox Biology 21. https://doi.org/10.1016/j.redox.2018.11.019
Ma W, Cojocaru R, Gotoh N, Gieser L, Villasmil R, Cogliati T, Swaroop A, Wong WT (2013) Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation. Neurobiology of Aging 34:2310–2321
Shen W, Lee SR, Araujo J, Chung SH, Zhu L, Gillies MC (2014) Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Muller cell ablation. Glia 62:1110–1124
Asih PR, Prikas E, Stefanoska K, Tan ARP, Ahel HI, Ittner A (2020) Functions of p38 MAP kinases in the central nervous system. Front Mol Neurosci 13:570586
Yao PL, Zhuo S, Mei H, Chen XF, Li N, Zhu TF, Chen ST, Wang JM, Hou RX, Le YY (2017) Androgen alleviates neurotoxicity of beta-amyloid peptide (Abeta) by promoting microglial clearance of Abeta and inhibiting microglial inflammatory response to Abeta. CNS Neurosci Ther 23:855–865
Gee MS, Son SH, Jeon SH, Do J, Kim N, Ju YJ, Lee SJ, Chung EK, Inn KS, Kim NJ, Lee JK (2020) A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse. Alzheimers Res Ther 12:45
Kasuya Y, Umezawa H, Hatano M (2018) Stress-activated protein kinases in spinal cord injury: focus on roles of p38. Int J Mol Sci 19. https://doi.org/10.3390/ijms19030867
Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, Cheung TH, Zhang B, Fu WY, Liew FY et al (2016) IL-33 ameliorates Alzheimerʼs disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A 113:E2705–E2713
Hanus J, Anderson C, Wang S (2015) RPE necroptosis in response to oxidative stress and in AMD. Ageing Res Rev 24:286–298
Kim J-E, Park H, Choi S-H, Kong M-J, Kang T-C (2019) Roscovitine attenuates microglia activation and monocyte infiltration via p38 MAPK inhibition in the rat frontoparietal cortex following status epilepticus. Cells 8. https://doi.org/10.3390/cells8070746
Conti P, Lauritano D, Caraffa A, Gallenga CE, Kritas SK, Ronconi G, Martinotti S (2020) Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. Eur J Pharmacol 875:173035
Ji RR, Suter MR (2007) p38 MAPK, microglial signaling, and neuropathic pain. Molecular pain 3:33
Datta S, Cano M, Ebrahimi K, Wang L, Handa JT (2017) The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 60:201–218
Esteve-Rudd J, Hazim RA, Diemer T, Paniagua AE, Volland S, Umapathy A, Williams DS (2018) Defective phagosome motility and degradation in cell nonautonomous RPE pathogenesis of a dominant macular degeneration. Proc Natl Acad Sci U S A 115:5468–5473
Kurihara T, Westenskow PD, Gantner ML, Usui Y, Schultz A, Bravo S, Aguilar E, Wittgrove C, Friedlander M, Paris LP et al (2016) Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration. eLife:5. https://doi.org/10.7554/eLife.14319
We are grateful to Binxin Wu (Tongji University School of Medicine, Shanghai, China) for technical assistance.
This work was supported by the National Natural Science Foundation of China (81570852, 81870667, 81970810, 81970811), the Science and Technology Commission of Shanghai Municipality (19495800700), and the Clinical Research and Cultivation Project of Shanghai Municipal Hospital, China (SHDC12019X30).
All procedures involving the animal studies were approved (Permit Number: SHDSYY-2020-2938) and conducted in accordance with the guidelines of the Committee on the Ethics of Animal Experiments of Tongji University School of Medicine and adhered to the principles of the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Consent to participate
Consent for publication
Written informed consent for publication was obtained from all participants.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wu, J., Gao, G., Shi, F. et al. Activated microglia–induced neuroinflammatory cytokines lead to photoreceptor apoptosis in Aβ-injected mice. J Mol Med (2021). https://doi.org/10.1007/s00109-021-02046-6
- Age-related macular degeneration
- Neuroinflammatory cytokines